Gene-marked EBV-specific T-cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene-marked EBV-specific T-cells, covering 2012-11-06 to 2012-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease [Phase 1]

See pricing